ACE inhibitors in the next millennium: a role in CHD?

    loading  Checking for direct PDF access through Ovid

Abstract

ACE inhibitor therapy is recognised as a primary treatment option for patients with heart failure, left ventricular dysfunction or hypertension. However, important experimental and clinical research is also evaluating the potential of ACE inhibitors in the treatment of a wider range of patients, including those with coronary heart disease (CHD). Details of this ongoing research and the rationale for this approach were discussed at a satellite symposium at the 20th Congress of the European Society of Cardiology [Vienna, Austria; August 1998] entitled ‘ACE inhibition and myocardial ischaemia: a new challenge for the third millennium’ and sponsored by the Servier Research Group.

Related Topics

    loading  Loading Related Articles